{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q16473",
      "entity_text" : "Xa",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P00734",
      "entity_text" : "prothrombin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In conclusion, we show that rivaroxaban is a more potent inhibitor of prothrombin activation because it inhibits factor Xa incorporated into prothrombinase more rapidly than apixaban.",
  "reading_complete" : "2020-08-02T12:32:57Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T12:30:02Z",
  "trigger" : "inhibits",
  "evidence" : [ "prothrombin activation because it inhibits factor Xa" ],
  "pmc_id" : "6524873",
  "score" : 0
}